Does RUCAPARIB CAMSYLATE Cause Oedema peripheral? 60 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 60 reports of Oedema peripheral have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 0.7% of all adverse event reports for RUCAPARIB CAMSYLATE.
60
Reports of Oedema peripheral with RUCAPARIB CAMSYLATE
0.7%
of all RUCAPARIB CAMSYLATE reports
3
Deaths
15
Hospitalizations
How Dangerous Is Oedema peripheral From RUCAPARIB CAMSYLATE?
Of the 60 reports, 3 (5.0%) resulted in death, 15 (25.0%) required hospitalization.
Is Oedema peripheral Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 60 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Oedema peripheral?
AMBRISENTAN (2,959)
TREPROSTINIL (2,816)
ADALIMUMAB (2,356)
LENALIDOMIDE (2,298)
AMLODIPINE (2,076)
PREDNISONE (2,029)
METHOTREXATE (1,939)
MACITENTAN (1,932)
RITUXIMAB (1,698)
TOCILIZUMAB (1,574)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Oedema peripheral Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE